Luisa Galli Selected Research

Luisa Galli Research Topics

Disease

44	Infections 12/2023 - 10/2002
18	Tuberculosis (Tuberculoses) 01/2022 - 02/2009
13	Fever (Fevers) 01/2020 - 08/2009
11	COVID-19 02/2024 - 01/2020
10	Communicable Diseases (Infectious Diseases) 01/2023 - 10/2011
9	HIV Infections (HIV Infection) 01/2022 - 02/2006
6	Cytomegalovirus Infections (Inclusion Disease) 12/2023 - 05/2007
5	Osteomyelitis 10/2022 - 01/2010
5	Neoplasms (Cancer) 12/2021 - 01/2007
5	Latent Tuberculosis 01/2019 - 01/2012
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 07/2007
4	Hypersensitivity (Allergy) 10/2023 - 01/2011
4	Malaria 08/2022 - 08/2010
4	Surgical Wound Infection 06/2022 - 02/2022
4	Vomiting 01/2018 - 02/2009
3	Pneumonia (Pneumonitis) 02/2024 - 01/2010
3	Pharyngitis (Sore Throat) 10/2023 - 01/2011
3	Rheumatic Fever (Acute Articular Rheumatism) 10/2023 - 01/2011
3	Sepsis (Septicemia) 04/2023 - 01/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 10/2019 - 09/2014
3	Human Influenza (Influenza) 01/2019 - 08/2010
3	Bacterial Infections (Bacterial Infection) 11/2017 - 08/2009
2	Viremia 01/2023 - 11/2018
2	Wounds and Injuries (Trauma) 04/2022 - 10/2016
2	Encephalitis (Encephalitis, Rasmussen) 04/2022 - 01/2020
2	Clinical Deterioration 01/2022 - 08/2009
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2022 - 01/2017
2	Disease Progression 01/2022 - 01/2021
2	Measles 01/2021 - 01/2020
2	Tetanus 08/2020 - 10/2016
2	Whooping Cough (Pertussis) 01/2019 - 03/2013
2	Virus Diseases (Viral Diseases) 01/2019 - 01/2011
2	Inflammation (Inflammations) 11/2018 - 05/2014
2	Asthma (Bronchial Asthma) 01/2017 - 08/2009
2	Febrile Seizures (Febrile Seizure) 01/2017 - 08/2009
2	Diarrhea 06/2005 - 10/2002
1	Leukopenia 02/2024
1	Leishmaniasis 03/2023
1	Visceral Leishmaniasis (Kala Azar) 03/2023
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2023
1	Impetigo (Impetigo Contagiosa) 01/2023
1	Hearing Loss (Hearing Impairment) 01/2023

Drug/Important Bio-Agent (IBA)

21	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 10/2002
9	VaccinesIBA 10/2023 - 08/2009
6	C-Reactive ProteinIBA 02/2024 - 01/2011
5	remdesivirIBA 02/2024 - 11/2021
5	Biomarkers (Surrogate Marker)IBA 03/2023 - 09/2018
5	Isoniazid (Ftivazide)FDA LinkGeneric 10/2021 - 02/2009
5	Tuberculin (PPD)IBA 03/2019 - 01/2014
5	AntipyreticsIBA 01/2018 - 08/2009
4	Valacyclovir (Valtrex)FDA LinkGeneric 12/2023 - 04/2021
4	Penicillins (Penicillin)FDA Link 10/2023 - 01/2011
4	ProcalcitoninIBA 10/2021 - 01/2011
4	GoldIBA 11/2019 - 09/2012
4	Ibuprofen (Motrin)FDA LinkGeneric 01/2017 - 08/2009
4	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017 - 08/2009
3	Antiviral Agents (Antivirals)IBA 02/2024 - 04/2022
3	MacrolidesIBA 10/2023 - 01/2011
3	Valganciclovir FDA Link 01/2023 - 05/2007
3	Immunoglobulin G (IgG)IBA 12/2022 - 01/2021
3	Immunoglobulin A (IgA)IBA 12/2022 - 05/2005
3	ArtesunateIBA 08/2022 - 08/2010
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2018
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2021 - 06/2005
3	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 08/2020 - 01/2017
3	Vitamin D FDA LinkGeneric 01/2016 - 12/2014
3	Interferon-gamma (Interferon, gamma)IBA 01/2014 - 06/2009
3	Linezolid (Zyvox)FDA Link 08/2012 - 01/2010
3	RNA (Ribonucleic Acid)IBA 07/2008 - 03/2002
2	Clindamycin (Cleocin)FDA LinkGeneric 10/2023 - 12/2021
2	sotrovimabIBA 08/2023 - 01/2023
2	Monoclonal AntibodiesIBA 08/2023 - 01/2022
2	AntigensIBA 01/2023 - 06/2012
2	Immunoglobulin E (IgE)IBA 01/2023 - 01/2021
2	Immunoglobulin M (IgM)IBA 12/2022 - 01/2022
2	Quinine (Quinson)FDA Link 08/2022 - 08/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2016
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2021 - 10/2002
2	Amoxicillin (Wymox)FDA LinkGeneric 12/2019 - 03/2017
2	Interleukin-2 (IL2)IBA 06/2019 - 01/2012
2	InterferonsIBA 01/2019 - 09/2014
2	Carbapenems (Carbapenem Antibiotics)IBA 12/2016 - 01/2016
2	GlycopeptidesIBA 01/2016 - 08/2012
1	beta-LactamsIBA 10/2023
1	First Generation CephalosporinsIBA 10/2023
1	P 500IBA 10/2023
1	taurolidineIBA 04/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	molnupiravirIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	IntegrasesIBA 01/2023

Therapy/Procedure

30	Therapeutics 02/2024 - 10/2002
9	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 01/2007
4	Operative Surgical Procedures 06/2022 - 02/2022
3	Critical Care (Surgical Intensive Care) 12/2020 - 01/2020
3	Rectal Administration 01/2018 - 12/2013
2	Length of Stay 02/2022 - 01/2016
2	Art Therapy 01/2022 - 01/2018
1	Catheters 04/2023
1	Central Venous Catheters 04/2023